Veronica Villani1, Carmine M Carapella2, Agostino Chiaravalloti3, Irene Terrenato4, Francesca Piludu5, Antonello Vidiri5, Orazio Schillaci6, Roberto Floris3, Simona Marzi7, Alessandra Fabi8, Andrea Pace9. 1. Neuro-Oncology Unit, Regina Elena National Cancer Institute, Rome, Italy villani@ifo.it. 2. Division of Neurosurgery, Regina Elena National Cancer Institute, Rome, Italy. 3. Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy. 4. Biostatistic Unit, Scientific Direction, Regina Elena National Cancer Institute, Rome, Italy. 5. Service of Neuroradiology, Regina Elena National Cancer Institute, Rome, Italy. 6. Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy IRCSS Neuromed, Pozzilli, Italy. 7. Medical Physics Laboratory, Regina Elena National Cancer Institute, Rome, Italy. 8. Division of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy. 9. Neuro-Oncology Unit, Regina Elena National Cancer Institute, Rome, Italy.
Abstract
AIM: The aim of the present study was to evaluate the prognostic value of 3,4-dihydroxy-6-[(18)F]-fluoro-L-phenylalanine ([(18)F]-FDOPA) positron-emission tomography (PET) in predicting the risk of radiological progression of disease in patients affected by low-grade glioma. PATIENTS AND METHODS: Patients affected by grade II glioma were consecutively enrolled in a prospective observational study at the Department of Neurology of Regina Elena National Cancer Institute in Rome, Italy. At enrolment, all patients underwent PET [(18)F]-FDOPA and Magnetic Resonance Imaging (MRI), and clinical and radiological assessments with MRI every six months to evaluate the progression of disease. RESULTS: A total of 50 patients affected by grade II glioma (30 males and 20 females) were included in the study. The multivariate analysis showed that standardized uptake value greater than 1.75 and disease duration were independent predictors of disease progression. CONCLUSION: These findings suggest that the PET [(18)F]-FDOPA may play an important prognostic role in evaluation of low-grade glioma. Copyright
AIM: The aim of the present study was to evaluate the prognostic value of 3,4-dihydroxy-6-[(18)F]-fluoro-L-phenylalanine ([(18)F]-FDOPA) positron-emission tomography (PET) in predicting the risk of radiological progression of disease in patients affected by low-grade glioma. PATIENTS AND METHODS: Patients affected by grade II glioma were consecutively enrolled in a prospective observational study at the Department of Neurology of Regina Elena National Cancer Institute in Rome, Italy. At enrolment, all patients underwent PET [(18)F]-FDOPA and Magnetic Resonance Imaging (MRI), and clinical and radiological assessments with MRI every six months to evaluate the progression of disease. RESULTS: A total of 50 patients affected by grade II glioma (30 males and 20 females) were included in the study. The multivariate analysis showed that standardized uptake value greater than 1.75 and disease duration were independent predictors of disease progression. CONCLUSION: These findings suggest that the PET [(18)F]-FDOPA may play an important prognostic role in evaluation of low-grade glioma. Copyright
Authors: Talia C Oughourlian; Jingwen Yao; Jacob Schlossman; Catalina Raymond; Matthew Ji; Hiroyuki Tatekawa; Noriko Salamon; Whitney B Pope; Johannes Czernin; Phioanh L Nghiemphu; Albert Lai; Timothy F Cloughesy; Benjamin M Ellingson Journal: J Neurooncol Date: 2020-01-24 Impact factor: 4.130
Authors: Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn Journal: Neuro Oncol Date: 2016-04-21 Impact factor: 12.300
Authors: A Verger; Ph Metellus; Q Sala; C Colin; E Bialecki; D Taieb; O Chinot; D Figarella-Branger; E Guedj Journal: Eur J Nucl Med Mol Imaging Date: 2017-03-14 Impact factor: 9.236
Authors: Maria C Rossi Espagnet; Andrea Romano; Valeria Mancuso; Francesco Cicone; Antonio Napolitano; Claudia Scaringi; Giuseppe Minniti; Alessandro Bozzao Journal: Br J Radiol Date: 2016-08-09 Impact factor: 3.039
Authors: Nina Poetsch; Adelheid Woehrer; Johanna Gesperger; Julia Furtner; Alexander R Haug; Dorothee Wilhelm; Georg Widhalm; Georgios Karanikas; Michael Weber; Ivo Rausch; Markus Mitterhauser; Wolfgang Wadsak; Marcus Hacker; Matthias Preusser; Tatjana Traub-Weidinger Journal: Neuro Oncol Date: 2018-02-19 Impact factor: 12.300
Authors: Hiroyuki Tatekawa; Hiroyuki Uetani; Akifumi Hagiwara; Jingwen Yao; Talia C Oughourlian; Issei Ueda; Catalina Raymond; Albert Lai; Timothy F Cloughesy; Phioanh L Nghiemphu; Linda M Liau; Shadfar Bahri; Whitney B Pope; Noriko Salamon; Benjamin M Ellingson Journal: J Neurooncol Date: 2021-03-11 Impact factor: 4.130